The decision brought an end to an unusually fierce campaign — fought in private and public — by Paris-based rival PAI ...

PARIS (Reuters) -French drugmaker Sanofi said on Thursday it was "surprised" by a renewed, higher offer for its consumer arm ...

Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the ...

PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year.

In its revised bid, PAI pledged to preserve headcount and raise investments at Opella's French production sites of Lisieux in Normandy and Compiegne, the source said. It also vowed to keep Opella's ...

Plus, James Gorman gets a promotion at Disney and how Jeff Yass turned gambling wins into a colossal trading giant ...

Advent International, Blackstone Inc., Groupe Bruxelles Lambert NV and PAI Partners have also proceeded into the next round ...

French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health business Opella, the Le Monde newspaper said on Thursday, as PAI seeks to outbid U.S. rival ...

Global software investor Insight Partners has closed its third continuation fund at about $1.5 billion. The fund was developed by the firm's liquidity committee and executed in partnership with ...

PAI Partners raises offer for Sanofi's consumer health unit, Opella, by €200 million and aims to keep key operations in ...